Corporate Development & Strategic Finance

Job Title : Manager Corporate Development & Strategic Finance

Location: Corporate Office, Jubilee Hills, Hyderabad

Reports to: Joint Managing Director (dotted line to Finance & Business Development)

Role Summary

The Manager Corporate Development & Strategic Finance will play a critical role in driving strategic growth initiatives and supporting enterprise-level financial decision-making. The position has two primary mandates:

1. Lead M&A and investment evaluation initiatives
2. Develop robust strategic and operational financial models supporting pricing, capacity planning, and portfolio prioritization decisions

This role operates at the intersection of strategy, finance, and business development, directly supporting senior leadership.

Key Responsibilities

Corporate Development & Transactions

• Lead valuation and transaction modelling for M&A, minority investments, joint ventures, and licensing opportunities (DCF, rNPV, comparable analysis, scenario modelling)
• Support due diligence processes by integrating commercial assumptions, manufacturing constraints, and regulatory timeline risks
• Develop comprehensive investment notes and leadership presentations highlighting value drivers, key risks, downside scenarios, and recommended deal structures

Strategic & Operational Finance

• Translate transaction models into long-term business cases supporting pipeline prioritization, pricing strategy, capacity allocation, and market entry decisions
• Develop ROI, IRR, and payback models for capital expenditure, technology transfers, and expansion programs
• Conduct sensitivity analysis and scenario planning, leveraging advanced analytical techniques (including Monte Carlo simulations, where appropriate)
• Prepare leadership KPI dashboards covering backlog coverage, win rates, margin analysis, cost-to-serve, and capital productivity metrics

Cross-Functional Collaboration

• Partner closely with Business Development on proposals and term sheet evaluations
• Work with Finance on costing structures, budgeting inputs, and financial planning
• Collaborate with Operations to incorporate yield assumptions, cycle times, and capacity constraints
• Engage with Regulatory teams to reflect timeline and compliance considerations in financial models

The role requires the ability to convert cross-functional inputs into clear, data-driven recommendations for senior management.

Candidate Profile

• 68 years of experience in Corporate Development, Investment Banking, or Strategic Finance with demonstrated ownership of financial modelling
• Advanced Excel modelling expertise, with the ability to build structured, auditable, and decision-ready financial models
• Strong analytical and presentation skills, with experience preparing executive-level materials
• Practical understanding of biopharmaceutical cost drivers and regulated (GxP) operating environments
• Exposure to CDMO/CMO pricing models and capacity planning frameworks preferred

About Biological E. Ltd

Biological E. Limited (BE), founded in 1953, is India's first private-sector biological products company and the first pharmaceutical company in South India. Originally incorporated as Biological Products Private Limited, BE develops, manufactures, and supplies vaccines and therapeutics.

BE's portfolio includes 12 World Health Organization (WHO)-approved vaccines and 11 USFDA-approved generic injectables. The company has the capability to develop and manufacture vaccines across all major technology platforms, including microbial/bacterial fermentation, recombinant vaccines, and viral vaccines. BE supplies essential and life-saving vaccines and pharmaceuticals to UN agencies such as UNICEF and PAHO, global markets, and within India to the National Immunisation Programme, State Governments, Public Sector Undertakings (PSUs), the Indian Armed Forces, and the domestic retail market.

For over five decades, BE has played a pivotal role in supporting public health programs in India. BE is the leading global supplier of Pentavalent vaccine and the largest producer of Tetanus vaccine worldwide. In India, it is the top producer of snake anti-venom and a prominent supplier of essential injectables, such as anti-coagulants. Additionally, BE offers trusted remedies for cough, cold, gastrointestinal disorders, respiratory issues, and critical care products.

In recent years, BE has undertaken strategic initiatives for organizational expansion, including developing generic injectable products for regulated markets, exploring synthetic biology and metabolic engineering for sustainable API manufacturing, and creating novel vaccines for global markets.

BE exports vaccines to over 140 countries, partnering with organizations such as the Bill & Melinda Gates Foundation. The company has delivered several million doses of LPV to children worldwide and distributed over two billion doses of vaccines to public and private markets globally. BE maintains a presence across nearly all continents.

BE's workforce of over 6,000 dedicated employees, including renowned scientists, attracts talent from around the world. The company operates three state-of-the-art facilities for development, scale-up, and commercial manufacturing in Hyderabad, India. These facilities are certified by the USFDA, WHO, and other regulatory bodies. BE collaborates with leading global organizations and government research institutes to create innovative vaccines and therapeutics, ensuring access to remote corners of the world and improving lives globally.

BE has received numerous awards and recognitions. Since 2014, it has been honoured with the Pharmexcil Award by the Ministry of Commerce and Industry, Government of India, for three consecutive years. In 2017, Fortune India's Next 500 included BE in its list. In 2022, Bio Spectrum, a leading pharma journal, ranked BE 6th among the top 20 biotechnology companies in India.